Đang chuẩn bị liên kết để tải về tài liệu:
Validation of the efficacy of the NUTRISCORE for the nutritional screening of cancer patients in China

Malnutrition is common in cancer patients. The NUTRISCORE is a newly developed cancer-specific nutritional screening tool and was validated by comparison with the Patient-Generated Subjective Global Assessment (PG-SGA) and Malnutrition Screening Tool (MST) in Spain. | Kang et al. BMC Cancer 2022 22 43 https doi.org 10.1186 s12885-021-09135-2 RESEARCH ARTICLE Open Access Validation of the efficacy of the NUTRISCORE for the nutritional screening of cancer patients in China Junren Kang Hailong Li Xiaodong Shi Enling Ma and Wei Chen Abstract Background Malnutrition is common in cancer patients. The NUTRISCORE is a newly developed cancer-specific nutritional screening tool and was validated by comparison with the Patient-Generated Subjective Global Assessment PG-SGA and Malnutrition Screening Tool MST in Spain. We aimed to evaluate the performance of the NUTRISCORE MST and PG-SGA in estimating the risk of malnutrition in Chinese cancer patients. Methods Data from an open parallel and multicenter cross-sectional study in 29 clinical teaching hospitals in 14 Chi- nese cities were used. Cancer patients were assessed for malnutrition using the PG-SGA NUTRISCORE and MST. The sensitivity specificity and areas under the receiver operating characteristic curve were estimated for the NUTRISCORE and MST using the PG-SGA as a reference. Results A total of 1000 cancer patients were included. The mean age was 55.9 19 to 92 years and 47.5 were male. Of these patients 450 45.0 had PG-SGA B and C 29 2.9 had a NUTRISCORE 5 and 367 36.7 had an MST 2. Using the PG-SGA as a reference the sensitivity specificity and area under the curve values of the NUTRISCORE were found to be 6.2 99.8 and 0.53 respectively. The sensitivity specificity and area under the curve values of the MST were 50.9 74.9 and 0.63 respectively. The kappa index between the NUTRISCORE and PG-SGA was 0.066 and that between the MST and PG-SGA was 0.262 P Kang et al. BMC Cancer 2022 22 43 Page 2 of 6 for cancer patients and validated by reference to the NUTRISCORE in the nutritional status of Chinese can- PG-SGA and Malnutrition Screening Tool MST 14 . cer patients. The NUTRISCORE was a cancer-specific malnutri- The NUTRISCORE was used to screen the nutritional tion assessment tool .